Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H27FN6O2 |
InChIKeyCGECJCJUHCZZGO-UHFFFAOYSA-N |
CAS Registry2083622-09-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 12 Dec 2016 |